Eight EU States Post $8.3 Bil. Diabetes Drug Spend - SmithKline Study
Executive Summary
Eight EU countries spent $8.3 bil. on type 2 diabetes drugs in 1998, according to initial results from a SmithKline Beecham-sponsored study presented to the European Association for the Study of Diabetes in Brussels Sept. 29.